{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:42:22Z","timestamp":1787020942891,"version":"build-2736575974"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["RO1-DK104375"],"award-info":[{"award-number":["RO1-DK104375"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01-DK074970; R01-DK107444"],"award-info":[{"award-number":["R01-DK074970; R01-DK107444"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["RO1-DK114321"],"award-info":[{"award-number":["RO1-DK114321"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Tulane SOM Faculty Research Pilot Funds Program"},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1TR003096"],"award-info":[{"award-number":["UL1TR003096"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["K12HD043451"],"award-info":[{"award-number":["K12HD043451"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Tullis-Tulane Alumni Chair in Diabetes"},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"crossref","award":["U54 GM104940"],"award-info":[{"award-number":["U54 GM104940"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["#BX003725"],"award-info":[{"award-number":["#BX003725"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Tulane Center of Excellence in Sex-Based Biology & Medicine"},{"name":"Ramadhyani-Bourgeois, MD Student Endowed Fund Award"},{"name":"Coordena\u03c2\u00e3o de Aperfei\u03c2oamento de Pessoal de Nivel Superior"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biol Sex Differ"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The soluble prorenin receptor (sPRR), a member of the renin-angiotensin system (RAS), is elevated in plasma of patients with preeclampsia, hypertension, chronic kidney disease (CKD), and type 2 diabetes. Our goal was to examine the relationship between sPRR and RAS activation to define whether sexual dimorphisms in sPRR might explain sex disparities in renal outcomes in patients with type 2 diabetes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Two hundred sixty-nine participants were included in the study (mean age, 48 \u00b1 16\u2009years; 42% men, 58% women), including 173 controls and 96 subjects with type 2 diabetes. In plasma and urine, we measured sPRR, plasma renin activity (PRA), and prorenin. In the urine, we also measured angiotensinogen along with other biomarkers of renal dysfunction.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Plasma sPRR and PRA were significantly higher in women with type 2 diabetes compared to men. In these women, plasma sPRR was positively correlated with PRA, age, and body mass index (BMI). In contrast, in men the sPRR in urine but not in plasma positively correlated with eGFR in urine, but negatively correlated with urine renin activity, plasma glucose, age,\u00a0and BMI.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In patients with type 2 diabetes, sPRR contributes to RAS stimulation in a sex-dependent fashion. In diabetic women, increased plasma sPRR parallels the activation of systemic RAS; while in diabetic men, decreased sPRR in urine matches intrarenal RAS stimulation. sPRR might be a potential indicator of intrarenal RAS activation and renal dysfunction in men and women with type 2 diabetes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13293-021-00374-3","type":"journal-article","created":{"date-parts":[[2021,5,3]],"date-time":"2021-05-03T08:16:39Z","timestamp":1620029799000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Sex differences in soluble prorenin receptor in patients with type 2 diabetes"],"prefix":"10.1186","volume":"12","author":[{"given":"Bruna","family":"Visniauskas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle Y.","family":"Arita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla B.","family":"Rosales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed A.","family":"Feroz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Luffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Accavitti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabrielle","family":"Dawkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew C.","family":"Curnow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina K.","family":"Thethi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.","family":"Lefante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edgar A.","family":"Jaimes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franck","family":"Mauvais-Jarvis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian A.","family":"Fonseca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0199-3193","authenticated-orcid":false,"given":"Minolfa C.","family":"Prieto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,1]]},"reference":[{"issue":"12","key":"374_CR1","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.2215\/CJN.11491116","volume":"12","author":"RZ Alicic","year":"2017","unstructured":"Alicic RZ, Rooney MT, Tuttle KR. Diabetic kidney disease: challenges, progress, and possibilities. Clin J Am Soc Nephrol. 2017;12(12):2032\u201345. https:\/\/doi.org\/10.2215\/CJN.11491116.","journal-title":"Clin J Am Soc Nephrol."},{"issue":"2","key":"374_CR2","doi-asserted-by":"publisher","first-page":"256","DOI":"10.2310\/JIM.0b013e31827c28bb","volume":"61","author":"H Kobori","year":"2013","unstructured":"Kobori H, Kamiyama M, Harrison-Bernard LM, Navar LG. Cardinal role of the intrarenal renin-angiotensin system in the pathogenesis of diabetic nephropathy. J Investig Med. 2013;61(2):256\u201364. https:\/\/doi.org\/10.2310\/JIM.0b013e31827c28bb.","journal-title":"J Investig Med."},{"issue":"5","key":"374_CR3","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1055\/s-0032-1331256","volume":"45","author":"YY Fan","year":"2013","unstructured":"Fan YY, Kobori H, Nakano D, Hitomi H, Mori H, Masaki T, et al. Aberrant activation of the intrarenal renin-angiotensin system in the developing kidneys of type 2 diabetic rats. Horm Metab Res. 2013;45(5):338\u201343. https:\/\/doi.org\/10.1055\/s-0032-1331256.","journal-title":"Horm Metab Res."},{"issue":"9933","key":"374_CR4","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1016\/S0140-6736(14)60040-4","volume":"383","author":"SA Peters","year":"2014","unstructured":"Peters SA, Huxley RR, Woodward M. Diabetes as a risk factor for stroke in women compared with men: a systematic review and meta-analysis of 64 cohorts, including 775,385 individuals and 12,539 strokes. Lancet. 2014;383(9933):1973\u201380. https:\/\/doi.org\/10.1016\/S0140-6736(14)60040-4.","journal-title":"Lancet."},{"issue":"11","key":"374_CR5","first-page":"1417","volume":"109","author":"G Nguyen","year":"2002","unstructured":"Nguyen G, Delarue F, Burckle C, Bouzhir L, Giller T, Sraer JD. Pivotal role of the renin\/prorenin receptor in angiotensin II production and cellular responses to renin. J ClinInvest. 2002;109(11):1417\u201327.","journal-title":"J ClinInvest."},{"issue":"3","key":"374_CR6","first-page":"483","volume":"18","author":"AH Nabi","year":"2006","unstructured":"Nabi AH, Kageshima A, Uddin MN, Nakagawa T, Park EY, Suzuki F. Binding properties of rat prorenin and renin to the recombinant rat renin\/prorenin receptor prepared by a baculovirus expression system. Int J Mol Med. 2006;18(3):483\u20138.","journal-title":"Int J Mol Med."},{"issue":"12","key":"374_CR7","doi-asserted-by":"publisher","first-page":"4810","DOI":"10.2741\/2429","volume":"12","author":"NA Nurun","year":"2007","unstructured":"Nurun NA, Uddin NM, Nakagawa T, Iwata H, Ichihara A, Inagami T, et al. Role of \"handle\" region of prorenin prosegment in the non-proteolytic activation of prorenin by binding to membrane anchored (pro)renin receptor. Front Biosci. 2007;12(12):4810\u20137. https:\/\/doi.org\/10.2741\/2429.","journal-title":"Front Biosci."},{"issue":"4","key":"374_CR8","doi-asserted-by":"publisher","first-page":"E810","DOI":"10.1152\/ajpendo.90264.2008","volume":"295","author":"J Zhang","year":"2008","unstructured":"Zhang J, Noble NA, Border WA, Owens RT, Huang Y. Receptor-dependent prorenin activation and induction of PAI-1 expression in vascular smooth muscle cells. Am J Physiol Endocrinol Metab. 2008;295(4):E810\u20139. https:\/\/doi.org\/10.1152\/ajpendo.90264.2008.","journal-title":"Am J Physiol Endocrinol Metab."},{"issue":"11","key":"374_CR9","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1111\/1440-1681.12813","volume":"44","author":"AA Gonzalez","year":"2017","unstructured":"Gonzalez AA, Zamora L, Reyes-Martinez C, Salinas-Parra N, Roldan N, Cuevas CA, et al. (Pro)renin receptor activation increases profibrotic markers and fibroblast-like phenotype through MAPK-dependent ROS formation in mouse renal collecting duct cells. Clin Exp Pharmacol Physiol. 2017;44(11):1134\u201344. https:\/\/doi.org\/10.1111\/1440-1681.12813.","journal-title":"Clin Exp Pharmacol Physiol."},{"issue":"2","key":"374_CR10","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1161\/HYPERTENSIONAHA.109.128645","volume":"54","author":"A Advani","year":"2009","unstructured":"Advani A, Kelly DJ, Cox AJ, White KE, Advani SL, Thai K, et al. The (Pro)renin receptor: site-specific and functional linkage to the vacuolar H + -ATPase in the kidney. Hypertension. 2009;54(2):261\u20139. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.109.128645.","journal-title":"Hypertension."},{"issue":"4","key":"374_CR11","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1161\/HYPERTENSIONAHA.110.167957","volume":"57","author":"AA Gonzalez","year":"2011","unstructured":"Gonzalez AA, Lara LS, Luffman C, Seth DM, Prieto MC. The soluble form of the prorenin receptor [s(PRR)] is augmented in the collecting ducts and in the urine of angiotensin II (Ang II)-dependent hypertensive rats. Hypertension. 2011;57(4):859\u201364. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.110.167957.","journal-title":"Hypertension."},{"issue":"4","key":"374_CR12","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1159\/000232199","volume":"30","author":"T Takemitsu","year":"2009","unstructured":"Takemitsu T, Ichihara A, Kaneshiro Y, Sakoda M, Kurauchi-Mito A, Narita T, et al. Association of (pro)renin receptor mRNA expression with angiotensin-converting enzyme mRNA expression in human artery. Am J Nephrol. 2009;30(4):361\u201370. https:\/\/doi.org\/10.1159\/000232199.","journal-title":"Am J Nephrol."},{"issue":"7","key":"374_CR13","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1016\/j.peptides.2010.04.003","volume":"31","author":"K Takahashi","year":"2010","unstructured":"Takahashi K, Yamamoto H, Hirose T, Hiraishi K, Shoji I, Shibasaki A, et al. Expression of (pro)renin receptor in human kidneys with end-stage kidney disease due to diabetic nephropathy. Peptides. 2010;31(7):1405\u20138. https:\/\/doi.org\/10.1016\/j.peptides.2010.04.003.","journal-title":"Peptides."},{"issue":"4","key":"374_CR14","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1111\/j.1440-1681.2011.05486.x","volume":"38","author":"J Huang","year":"2011","unstructured":"Huang J, Matavelli LC, Siragy HM. Renal (pro)renin receptor contributes to development of diabetic kidney disease through transforming growth factor-beta1-connective tissue growth factor signalling cascade. Clin Exp Pharmacol Physiol. 2011;38(4):215\u201321. https:\/\/doi.org\/10.1111\/j.1440-1681.2011.05486.x.","journal-title":"Clin Exp Pharmacol Physiol."},{"issue":"Supplement 1","key":"374_CR15","doi-asserted-by":"publisher","first-page":"S63","DOI":"10.1016\/j.diabres.2008.09.027","volume":"82","author":"A Ichihara","year":"2008","unstructured":"Ichihara A, Sakoda M, Mito-Kurauchi A, Itoh H. Activated prorenin as a therapeutic target for diabetic nephropathy. Diabetes Res Clin Pract. 2008;82(Supplement 1):S63\u2013S6.","journal-title":"Diabetes Res Clin Pract"},{"issue":"6","key":"374_CR16","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1161\/HYPERTENSIONAHA.108.127258","volume":"53","author":"C Cousin","year":"2009","unstructured":"Cousin C, Bracquart D, Contrepas A, Corvol P, Muller L, Nguyen G. Soluble form of the (pro)renin receptor generated by intracellular cleavage by furin is secreted in plasma. Hypertension. 2009;53(6):1077\u201382. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.108.127258.","journal-title":"Hypertension."},{"issue":"4","key":"374_CR17","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1093\/jb\/mvw080","volume":"161","author":"T Nakagawa","year":"2017","unstructured":"Nakagawa T, Suzuki-Nakagawa C, Watanabe A, Asami E, Matsumoto M, Nakano M, et al. Site-1 protease is required for the generation of soluble (pro)renin receptor. J Biochem. 2017;161(4):369\u201379. https:\/\/doi.org\/10.1093\/jb\/mvw080.","journal-title":"J Biochem."},{"issue":"5","key":"374_CR18","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/hr.2010.284","volume":"34","author":"A Yoshikawa","year":"2011","unstructured":"Yoshikawa A, Aizaki Y, Kusano K, Kishi F, Susumu T, Iida S, et al. The (pro)renin receptor is cleaved by ADAM19 in the Golgi leading to its secretion into extracellular space. Hypertension research : official journal of the Japanese Society of Hypertension. 2011;34(5):599\u2013605. https:\/\/doi.org\/10.1038\/hr.2010.284.","journal-title":"Hypertension research : official journal of the Japanese Society of Hypertension."},{"issue":"6","key":"374_CR19","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1007\/s10157-013-0803-y","volume":"17","author":"K Hamada","year":"2013","unstructured":"Hamada K, Taniguchi Y, Shimamura Y, Inoue K, Ogata K, Ishihara M, et al. Serum level of soluble (pro)renin receptor is modulated in chronic kidney disease. Clin Exp Nephrol. 2013;17(6):848\u201356. https:\/\/doi.org\/10.1007\/s10157-013-0803-y.","journal-title":"Clin Exp Nephrol."},{"key":"374_CR20","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.peptides.2014.03.008","volume":"56","author":"T Nishijima","year":"2014","unstructured":"Nishijima T, Tajima K, Takahashi K, Sakurai S. Elevated plasma levels of soluble (pro)renin receptor in patients with obstructive sleep apnea syndrome: association with polysomnographic parameters. Peptides. 2014;56:14\u201321. https:\/\/doi.org\/10.1016\/j.peptides.2014.03.008.","journal-title":"Peptides."},{"issue":"10","key":"374_CR21","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1093\/ajh\/hpv019","volume":"28","author":"J Thomason","year":"2015","unstructured":"Thomason J, Reyes M, Allen SR, Jones RO, Beeram MR, Kuehl TJ, et al. Elevation of (pro)renin and (pro)renin receptor in preeclampsia. Am J Hypertens. 2015;28(10):1277\u201384. https:\/\/doi.org\/10.1093\/ajh\/hpv019.","journal-title":"Am J Hypertens."},{"issue":"7","key":"374_CR22","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1038\/hr.2014.46","volume":"37","author":"S Morimoto","year":"2014","unstructured":"Morimoto S, Ando T, Niiyama M, Seki Y, Yoshida N, Watanabe D, et al. Serum soluble (pro)renin receptor levels in patients with essential hypertension. Hypertension research : official journal of the Japanese Society of Hypertension. 2014;37(7):642\u20138. https:\/\/doi.org\/10.1038\/hr.2014.46.","journal-title":"Hypertension research : official journal of the Japanese Society of Hypertension."},{"issue":"8","key":"374_CR23","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1007\/s001250051260","volume":"42","author":"J Deinum","year":"1999","unstructured":"Deinum J, R\u00f8nn B, Mathiesen E, Derkx FH, Hop WC, Schalekamp MA. Increase in serum prorenin precedes onset of microalbuminuria in patients with insulin-dependent diabetes mellitus. Diabetologia. 1999;42(8):1006\u201310. https:\/\/doi.org\/10.1007\/s001250051260.","journal-title":"Diabetologia."},{"issue":"1","key":"374_CR24","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S1056-8727(98)00020-8","volume":"13","author":"L Davies","year":"1999","unstructured":"Davies L, Fulcher GR, Atkins A, Frumar K, Monaghan J, Stokes G, et al. The relationship of prorenin values to microvascular complications in patients with insulin-dependent diabetes mellitus. J Diabetes Complications. 1999;13(1):45\u201351. https:\/\/doi.org\/10.1016\/S1056-8727(98)00020-8.","journal-title":"J Diabetes Complications."},{"issue":"22","key":"374_CR25","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1056\/NEJM198505303122202","volume":"312","author":"JA Luetscher","year":"1985","unstructured":"Luetscher JA, Kraemer FB, Wilson DM, Schwartz HC, Bryer-Ash M. Increased plasma inactive renin in diabetes mellitus. A marker of microvascular complications. N Engl J Med. 1985;312(22):1412\u20137. https:\/\/doi.org\/10.1056\/NEJM198505303122202.","journal-title":"N Engl J Med."},{"issue":"2","key":"374_CR26","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1161\/HYPERTENSIONAHA.113.02217","volume":"63","author":"G Nguyen","year":"2014","unstructured":"Nguyen G, Blanchard A, Curis E, Bergerot D, Chambon Y, Hirose T, et al. Plasma soluble (pro)renin receptor is independent of plasma renin, prorenin, and aldosterone concentrations but is affected by ethnicity. Hypertension. 2014;63(2):297\u2013302. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.113.02217.","journal-title":"Hypertension."},{"issue":"3","key":"374_CR27","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1210\/er.2016-1146","volume":"38","author":"F Mauvais-Jarvis","year":"2017","unstructured":"Mauvais-Jarvis F, Manson JE, Stevenson JC, Fonseca VA. Menopausal hormone therapy and type 2 diabetes prevention: evidence, mechanisms, and clinical implications. Endocr Rev. 2017;38(3):173\u201388. https:\/\/doi.org\/10.1210\/er.2016-1146.","journal-title":"Endocr Rev."},{"issue":"3","key":"374_CR28","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/nrneph.2017.189","volume":"14","author":"KMM Colafella","year":"2018","unstructured":"Colafella KMM, Denton KM. Sex-specific differences in hypertension and associated cardiovascular disease. Nat Rev Nephrol. 2018;14(3):185\u2013201. https:\/\/doi.org\/10.1038\/nrneph.2017.189.","journal-title":"Nat Rev Nephrol."},{"issue":"2","key":"374_CR29","doi-asserted-by":"publisher","first-page":"F456","DOI":"10.1152\/ajprenal.00249.2019","volume":"317","author":"BD Shepard","year":"2019","unstructured":"Shepard BD. Sex differences in diabetes and kidney disease: mechanisms and consequences. Am J Physiol Renal Physiol. 2019;317(2):F456\u2013F62. https:\/\/doi.org\/10.1152\/ajprenal.00249.2019.","journal-title":"Am J Physiol Renal Physiol."},{"issue":"6","key":"374_CR30","doi-asserted-by":"publisher","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","volume":"130","author":"AS Levey","year":"1999","unstructured":"Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130(6):461\u201370. https:\/\/doi.org\/10.7326\/0003-4819-130-6-199903160-00002.","journal-title":"Ann Intern Med."},{"issue":"8","key":"374_CR31","doi-asserted-by":"publisher","first-page":"3176","DOI":"10.1093\/ndt\/gfs011","volume":"27","author":"KT Mills","year":"2012","unstructured":"Mills KT, Kobori H, Hamm LL, Alper AB, Khan IE, Rahman M, et al. Increased urinary excretion of angiotensinogen is associated with risk of chronic kidney disease. Nephrol Dial Transplant. 2012;27(8):3176\u201381. https:\/\/doi.org\/10.1093\/ndt\/gfs011.","journal-title":"Nephrol Dial Transplant."},{"issue":"4","key":"374_CR32","doi-asserted-by":"publisher","first-page":"635","DOI":"10.2337\/dc18-2029","volume":"42","author":"T Du","year":"2019","unstructured":"Du T, Fernandez C, Barshop R, Guo Y, Krousel-Wood M, Chen W, et al. Sex differences in cardiovascular risk profile from childhood to midlife between individuals who did and did not develop diabetes at follow-up: the bogalusa heart study. Diabetes Care. 2019;42(4):635\u201343. https:\/\/doi.org\/10.2337\/dc18-2029.","journal-title":"Diabetes Care."},{"issue":"5","key":"374_CR33","doi-asserted-by":"publisher","first-page":"C547","DOI":"10.1152\/ajpcell.00146.2013","volume":"305","author":"WH Dong","year":"2013","unstructured":"Dong WH, Chen JC, He YL, Xu JJ, Mei YA. Resveratrol inhibits K(v)2.2 currents through the estrogen receptor GPR30-mediated PKC pathway. Am J Physiol Cell Physiol. 2013;305(5):C547\u201357. https:\/\/doi.org\/10.1152\/ajpcell.00146.2013.","journal-title":"Am J Physiol Cell Physiol."},{"key":"374_CR34","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.atherosclerosis.2018.01.043","volume":"270","author":"EN Kim","year":"2018","unstructured":"Kim EN, Kim MY, Lim JH, Kim Y, Shin SJ, Park CW, et al. The protective effect of resveratrol on vascular aging by modulation of the renin-angiotensin system. Atherosclerosis. 2018;270:123\u201331. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2018.01.043.","journal-title":"Atherosclerosis."},{"key":"374_CR35","doi-asserted-by":"publisher","first-page":"155","DOI":"10.3389\/fendo.2013.00155","volume":"4","author":"KJ Binger","year":"2013","unstructured":"Binger KJ, Muller DN. Autophagy and the (pro)renin receptor. Front Endocrinol (Lausanne). 2013;4:155. https:\/\/doi.org\/10.3389\/fendo.2013.00155.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"6","key":"374_CR36","doi-asserted-by":"publisher","first-page":"2528","DOI":"10.1210\/jc.2012-4139","volume":"98","author":"N Watanabe","year":"2013","unstructured":"Watanabe N, Morimoto S, Fujiwara T, Suzuki T, Taniguchi K, Mori F, et al. Prediction of gestational diabetes mellitus by soluble (pro)renin receptor during the first trimester. J Clin Endocrinol Metab. 2013;98(6):2528\u201335. https:\/\/doi.org\/10.1210\/jc.2012-4139.","journal-title":"J Clin Endocrinol Metab."},{"issue":"1","key":"374_CR37","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13293-016-0110-x","volume":"7","author":"G Barsha","year":"2016","unstructured":"Barsha G, Denton KM, Mirabito Colafella KM. Sex- and age-related differences in arterial pressure and albuminuria in mice. Biol Sex Differ. 2016;7(1):57. https:\/\/doi.org\/10.1186\/s13293-016-0110-x.","journal-title":"Biol Sex Differ."},{"issue":"8","key":"374_CR38","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1093\/ndt\/14.8.1904","volume":"14","author":"J Deinum","year":"1999","unstructured":"Deinum J, Tarnow L, van Gool JM, de Bruin RA, Derkx FH, Schalekamp MA, et al. Plasma renin and prorenin and renin gene variation in patients with insulin-dependent diabetes mellitus and nephropathy. Nephrol DialTransplant. 1999;14(8):1904\u201311. https:\/\/doi.org\/10.1093\/ndt\/14.8.1904.","journal-title":"Nephrol DialTransplant."},{"issue":"6","key":"374_CR39","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1097\/00004872-199816060-00017","volume":"16","author":"AH Danser","year":"1998","unstructured":"Danser AH, Derkx FH, Schalekamp MA, Hense HW, Riegger GA, Schunkert H. Determinants of interindividual variation of renin and prorenin concentrations: evidence for a sexual dimorphism of (pro)renin levels in humans. J Hypertens. 1998;16(6):853\u201362. https:\/\/doi.org\/10.1097\/00004872-199816060-00017.","journal-title":"J Hypertens."},{"issue":"10","key":"374_CR40","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1093\/ajh\/hpv045","volume":"28","author":"AH Danser","year":"2015","unstructured":"Danser AH. The role of the (pro)renin receptor in hypertensive disease. Am J Hypertens. 2015;28(10):1187\u201396. https:\/\/doi.org\/10.1093\/ajh\/hpv045.","journal-title":"Am J Hypertens."},{"issue":"2","key":"374_CR41","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1128\/MCB.25.2.575-589.2005","volume":"25","author":"YY Sautin","year":"2005","unstructured":"Sautin YY, Lu M, Gaugler A, Zhang L, Gluck SL. Phosphatidylinositol 3-kinase-mediated effects of glucose on vacuolar H+-ATPase assembly, translocation, and acidification of intracellular compartments in renal epithelial cells. Mol Cell Biol. 2005;25(2):575\u201389. https:\/\/doi.org\/10.1128\/MCB.25.2.575-589.2005.","journal-title":"Mol Cell Biol."},{"issue":"6","key":"374_CR42","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1159\/000013415","volume":"18","author":"H Sato","year":"1998","unstructured":"Sato H, Iwano M, Akai Y, Kurioka H, Kubo A, Yamaguchi T, et al. Increased excretion of urinary transforming growth factor beta 1 in patients with diabetic nephropathy. Am J Nephrol. 1998;18(6):490\u20134. https:\/\/doi.org\/10.1159\/000013415.","journal-title":"Am J Nephrol."},{"issue":"1","key":"374_CR43","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.bjbas.2014.02.002","volume":"3","author":"YM Shaker","year":"2014","unstructured":"Shaker YM, Soliman HA, Ezzat E, Hussein NS, Ashour E, Donia A, et al. Serum and urinary transforming growth factor beta 1 as biochemical markers in diabetic nephropathy patients. Beni-Suef Univ J Basic Appl Sci. 2014;3(1):16\u201323. https:\/\/doi.org\/10.1016\/j.bjbas.2014.02.002.","journal-title":"Beni-Suef Univ J Basic Appl Sci"},{"issue":"6","key":"374_CR44","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1161\/HYPERTENSIONAHA.107.107268","volume":"51","author":"JJ Kang","year":"2008","unstructured":"Kang JJ, Toma I, Sipos A, Meer EJ, Vargas SL, Peti-Peterdi J. The collecting duct is the major source of prorenin in diabetes. Hypertension. 2008;51(6):1597\u2013604. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.107.107268.","journal-title":"Hypertension."},{"issue":"5","key":"374_CR45","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.jash.2008.04.009","volume":"2","author":"A Ichihara","year":"2009","unstructured":"Ichihara A, Sakoda M, Kurauchi-Mito A, Nishiyama A, Itoh H. Involvement of receptor-bound prorenin in development of nephropathy in diabetic db\/db mice. J Am Soc Hypertension. 2009;2(5):332\u201340.","journal-title":"J Am Soc Hypertension."},{"issue":"6","key":"374_CR46","doi-asserted-by":"publisher","first-page":"F1243","DOI":"10.1152\/ajprenal.00152.2017","volume":"313","author":"MC Prieto","year":"2017","unstructured":"Prieto MC, Reverte V, Mamenko M, Kuczeriszka M, Veiras LC, Rosales CB, et al. Collecting duct prorenin receptor knockout reduces renal function, increases sodium excretion, and mitigates renal responses in ANG II-induced hypertensive mice. Am J Physiol Renal Physiol. 2017;313(6):F1243\u2013F53. https:\/\/doi.org\/10.1152\/ajprenal.00152.2017.","journal-title":"Am J Physiol Renal Physiol."},{"issue":"11","key":"374_CR47","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1097\/HJH.0b013e32834bbcbf","volume":"29","author":"M van den Heuvel","year":"2011","unstructured":"van den Heuvel M, Batenburg WW, Jainandunsing S, Garrelds IM, van Gool JM, Feelders RA, et al. Urinary renin, but not angiotensinogen or aldosterone, reflects the renal renin-angiotensin-aldosterone system activity and the efficacy of renin-angiotensin-aldosterone system blockade in the kidney. J Hypertens. 2011;29(11):2147\u201355. https:\/\/doi.org\/10.1097\/HJH.0b013e32834bbcbf.","journal-title":"J Hypertens."},{"issue":"1","key":"374_CR48","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1161\/HYPERTENSIONAHA.119.12873","volume":"74","author":"J Tang","year":"2019","unstructured":"Tang J, Wysocki J, Ye M, Valles PG, Rein J, Shirazi M, et al. Urinary renin in patients and mice with diabetic kidney disease. Hypertension. 2019;74(1):83\u201394. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.119.12873.","journal-title":"Hypertension."},{"key":"374_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/DMSO.S91245","volume":"9","author":"A Tojo","year":"2016","unstructured":"Tojo A, Kinugasa S, Fujita T, Wilcox CS. A local renal renin-angiotensin system activation via renal uptake of prorenin and angiotensinogen in diabetic rats. Diabetes Metab Syndr Obes. 2016;9:1\u201310. https:\/\/doi.org\/10.2147\/DMSO.S91245.","journal-title":"Diabetes Metab Syndr Obes."},{"issue":"4","key":"374_CR50","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1007\/s11906-020-01037-1","volume":"22","author":"Y Sun","year":"2020","unstructured":"Sun Y, Lu X, Danser AHJ. Megalin: a novel determinant of renin-angiotensin system activity in the kidney? Curr Hypertens Rep. 2020;22(4):30. https:\/\/doi.org\/10.1007\/s11906-020-01037-1.","journal-title":"Curr Hypertens Rep"},{"issue":"5","key":"374_CR51","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1161\/HYPERTENSIONAHA.115.07012","volume":"67","author":"LC Roksnoer","year":"2016","unstructured":"Roksnoer LC, Heijnen BF, Nakano D, Peti-Peterdi J, Walsh SB, Garrelds IM, et al. On the origin of urinary renin: a translational approach. Hypertension. 2016;67(5):927\u201333. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.115.07012.","journal-title":"Hypertension."},{"issue":"7","key":"374_CR52","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.2215\/CJN.12661213","volume":"9","author":"LC Roksnoer","year":"2014","unstructured":"Roksnoer LC, Verdonk K, Garrelds IM, van Gool JM, Zietse R, Hoorn EJ, et al. Methodologic issues in the measurement of urinary renin. Clin J Am Soc Nephrol. 2014;9(7):1163\u20137. https:\/\/doi.org\/10.2215\/CJN.12661213.","journal-title":"Clin J Am Soc Nephrol."},{"issue":"11","key":"374_CR53","doi-asserted-by":"publisher","first-page":"2696","DOI":"10.1681\/ASN.2018050522","volume":"29","author":"CD Schuh","year":"2018","unstructured":"Schuh CD, Polesel M, Platonova E, Haenni D, Gassama A, Tokonami N, et al. Combined structural and functional imaging of the kidney reveals major axial differences in proximal tubule endocytosis. J Am Soc Nephrol. 2018;29(11):2696\u2013712. https:\/\/doi.org\/10.1681\/ASN.2018050522.","journal-title":"J Am Soc Nephrol."},{"issue":"7","key":"374_CR54","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1042\/CS20130140","volume":"125","author":"R Maranon","year":"2013","unstructured":"Maranon R, Reckelhoff JF. Sex and gender differences in control of blood pressure. Clin Sci (Lond). 2013;125(7):311\u20138. https:\/\/doi.org\/10.1042\/CS20130140.","journal-title":"Clin Sci (Lond)."},{"issue":"3","key":"374_CR55","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1093\/ehjcvp\/pvw042","volume":"3","author":"J Tamargo","year":"2017","unstructured":"Tamargo J, Rosano G, Walther T, Duarte J, Niessner A, Kaski JC, et al. Gender differences in the effects of cardiovascular drugs. Eur Heart J Cardiovasc Pharmacother. 2017;3(3):163\u201382. https:\/\/doi.org\/10.1093\/ehjcvp\/pvw042.","journal-title":"Eur Heart J Cardiovasc Pharmacother."},{"key":"374_CR56","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.compchemeng.2018.02.009","volume":"112","author":"J Leete","year":"2018","unstructured":"Leete J, Gurley S, Layton A. Modeling sex differences in the renin angiotensin system and the efficacy of antihypertensive therapies. Comput Chem Eng. 2018;112:253\u201364. https:\/\/doi.org\/10.1016\/j.compchemeng.2018.02.009.","journal-title":"Comput Chem Eng."},{"key":"374_CR57","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.compbiomed.2018.11.002","volume":"104","author":"J Leete","year":"2018","unstructured":"Leete J, Layton AT. Sex-specific long-term blood pressure regulation: modeling and analysis. Comput Biol Med. 2018;104:139\u201348. https:\/\/doi.org\/10.1016\/j.compbiomed.2018.11.002.","journal-title":"Comput Biol Med."},{"issue":"4","key":"374_CR58","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1159\/000499597","volume":"49","author":"TC Woods","year":"2019","unstructured":"Woods TC, Satou R, Miyata K, Katsurada A, Dugas CM, Klingenberg NC, et al. Canagliflozin prevents intrarenal angiotensinogen augmentation and mitigates kidney injury and hypertension in mouse model of type 2 diabetes mellitus. Am J Nephrol. 2019;49(4):331\u201342. https:\/\/doi.org\/10.1159\/000499597.","journal-title":"Am J Nephrol."},{"issue":"7","key":"374_CR59","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1136\/jim-2017-000445","volume":"65","author":"T Yoshimoto","year":"2017","unstructured":"Yoshimoto T, Furuki T, Kobori H, Miyakawa M, Imachi H, Murao K, et al. Effects of sodium-glucose cotransporter 2 inhibitors on urinary excretion of intact and total angiotensinogen in patients with type 2 diabetes. J Investig Med. 2017;65(7):1057\u201361. https:\/\/doi.org\/10.1136\/jim-2017-000445.","journal-title":"J Investig Med."},{"issue":"1","key":"374_CR60","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41598-017-18314-w","volume":"8","author":"K Narumi","year":"2018","unstructured":"Narumi K, Sato E, Hirose T, Yamamoto T, Nakamichi T, Miyazaki M, et al. (Pro)renin receptor is involved in mesangial fibrosis and matrix expansion. Sci Rep. 2018;8(1):16. https:\/\/doi.org\/10.1038\/s41598-017-18314-w.","journal-title":"Sci Rep"},{"issue":"12","key":"374_CR61","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1056\/NEJMoa011303","volume":"345","author":"EJ Lewis","year":"2001","unstructured":"Lewis EJ, Hunsicker LG, Clarke WR, Berl T, Pohl MA, Lewis JB, et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med. 2001;345(12):851\u201360. https:\/\/doi.org\/10.1056\/NEJMoa011303.","journal-title":"N Engl J Med."},{"issue":"7","key":"374_CR62","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1172\/jci.insight.128061","volume":"5","author":"F Wang","year":"2020","unstructured":"Wang F, Luo R, Zou CJ, Xie S, Peng K, Zhao L, et al. Soluble (pro)renin receptor treats metabolic syndrome in mice with diet-induced obesity via interaction with PPARgamma. JCI Insight. 2020;5(7):7. https:\/\/doi.org\/10.1172\/jci.insight.128061.","journal-title":"JCI Insight."}],"container-title":["Biology of Sex Differences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13293-021-00374-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13293-021-00374-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13293-021-00374-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,21]],"date-time":"2021-07-21T03:11:14Z","timestamp":1626837074000},"score":1,"resource":{"primary":{"URL":"https:\/\/bsd.biomedcentral.com\/articles\/10.1186\/s13293-021-00374-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,1]]},"references-count":62,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["374"],"URL":"https:\/\/doi.org\/10.1186\/s13293-021-00374-3","relation":{},"ISSN":["2042-6410"],"issn-type":[{"value":"2042-6410","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,1]]},"assertion":[{"value":"6 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study protocol was approved by Tulane Institutional Review Board (#13-460293E) and written informed consent was obtained for all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"33"}}